Literature DB >> 4260263

Decarboxylation of orally administered L-dopa in the human digestive tract.

J Bergmark, A Carlsson, A K Granerus, R Jagenburg, T Magnusson, A Svanborg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4260263     DOI： 10.1007/bf00501249

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  2 in total

1.  L-3,4-dihydroxyphenylalanine metabolism by the gut in vitro.

Authors:  L Rivera-Calimlim; J P Morgan; C A Dujovne; J R Bianchine; L Lasagna
Journal:  Biochem Pharmacol       Date:  1971-11       Impact factor: 5.858

2.  Drug-induced changes of extracerebral dopa metabolism in man.

Authors:  R Tissot; G Bartholini; A Pletscher
Journal:  Arch Neurol       Date:  1969-02
  2 in total
  7 in total

1.  The role of the liver in the clearance of l-dope from plasma.

Authors:  P T Mearrick; G G Graham; D N Wade
Journal:  J Pharmacokinet Biopharm       Date:  1975-02

2.  Intestinal decarboxylation of L-Dopa in relation to dose requirement in Parkinson's disease.

Authors:  A K Granerus; R Jagenburg; A Svanborg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

Review 3.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

Review 4.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

5.  The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.

Authors:  H Lennernäs; D Nilsson; S M Aquilonius; O Ahrenstedt; L Knutson; L K Paalzow
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

6.  Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.

Authors:  R Katzenschlager; A Evans; A Manson; P N Patsalos; N Ratnaraj; H Watt; L Timmermann; R Van der Giessen; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

Review 7.  Chemical transformation of xenobiotics by the human gut microbiota.

Authors:  Nitzan Koppel; Vayu Maini Rekdal; Emily P Balskus
Journal:  Science       Date:  2017-06-23       Impact factor: 47.728
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.